Danaher Corporation (DHR) : Cortland Associates Incmo reduced its stake in Danaher Corporation by 32.47% during the most recent quarter end. The investment management company now holds a total of 312,089 shares of Danaher Corporation which is valued at $30,306,963 after selling 150,058 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on May 3, 2016.Danaher Corporation makes up approximately 6.43% of Cortland Associates Incmo’s portfolio.
Other Hedge Funds, Including , Parkside Financial Bank Trust reduced its stake in DHR by selling 44 shares or 20.47% in the most recent quarter. The Hedge Fund company now holds 171 shares of DHR which is valued at $16,606. Danaher Corporation makes up approx 0.01% of Parkside Financial Bank Trust’s portfolio.Bank Of Stockton boosted its stake in DHR in the latest quarter, The investment management firm added 647 additional shares and now holds a total of 2,870 shares of Danaher Corporation which is valued at $277,673. Danaher Corporation makes up approx 0.15% of Bank Of Stockton’s portfolio.Lafleur Godfrey boosted its stake in DHR in the latest quarter, The investment management firm added 1,026 additional shares and now holds a total of 72,261 shares of Danaher Corporation which is valued at $6,991,252. Danaher Corporation makes up approx 2.13% of Lafleur Godfrey’s portfolio.Sumitomo Life Insurance Co reduced its stake in DHR by selling 873 shares or 2.94% in the most recent quarter. The Hedge Fund company now holds 28,826 shares of DHR which is valued at $2,788,916. Danaher Corporation makes up approx 0.36% of Sumitomo Life Insurance Co’s portfolio.Douglass Winthrop Advisors reduced its stake in DHR by selling 70 shares or 0.33% in the most recent quarter. The Hedge Fund company now holds 21,045 shares of DHR which is valued at $2,036,104. Danaher Corporation makes up approx 0.15% of Douglass Winthrop Advisors’s portfolio.
Danaher Corporation opened for trading at $97.49 and hit $98.34 on the upside on Tuesday, eventually ending the session at $98.32, with a gain of 1.30% or 1.26 points. The heightened volatility saw the trading volume jump to 18,96,572 shares. Company has a market cap of $67,713 M.
On the company’s financial health, Danaher Corporation reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Apr 21, 2016. Analyst had a consensus of $1.03. The company had revenue of $5387.20 million for the quarter, compared to analysts expectations of $5329.83 million. The company’s revenue was up 14.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.93 EPS.
Many Wall Street Analysts have commented on Danaher Corporation. Company shares were Reiterated by RBC Capital Mkts on Apr 22, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 96 from a previous price target of $87 .Company shares were Reiterated by Stifel on Apr 22, 2016 to “Buy”, Firm has raised the Price Target to $ 110 from a previous price target of $109 .Company shares were Reiterated by Barclays on Apr 22, 2016 to “Overweight”, Firm has raised the Price Target to $ 105 from a previous price target of $104 .
Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.